Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.
A new instrument that has the potential to help minimize the spread of antimicrobial resistance is revealing early potential, by using a bacterial immune system as a gene-editing tool.
Weed killers of the future could soon be based on failed antibiotics.
Researchers at Karolinska Institutet have developed a molecular method able to detect whether or not bacteria respond to antibiotics within minutes.
The deadly hospital pathogen Acinetobacter baumannii can live for a year on a hospital wall without food and water. Then, when it infects a vulnerable patient, it resists antibiotics as well as the body's built-in infection-fighting response.
An old antibiotic may provide much-needed protection against multi-drug resistant bacterial infections, according to a new study publishing May 16th in the open access journal PLOS Biology by James Kirby of Harvard Medical School, US, and colleagues.
Candida auris is an extremely new species among yeasts from the Candida genus that cause infections in humans: it was only reported in 2009, and no evidence has been found prior to the 1990s.
The spread of drug-resistant microbes has become a global health concern that threatens our ability to treat infections.
Clostridioides difficile (C. difficile) is a bacterium that can infect the large intestine, with symptoms ranging from diarrhea to life-threatening colon damage.
Much of what is now considered modern medicine originated as folk remedies or traditional, Indigenous practices. These customs are still alive today, and they could help address a variety of conditions.
Fungi produce metabolites that humans have used to improve health. For example, they secrete penicillin, which is then purified and used as an antibiotic for humans, leading to the development of many other antibiotics.
Many people have experienced infections from E. coli, which are primarily seen as inconvenient and unpleasant.
"Know thy self; know thy enemy" - Sun Tzu. That quote is from centuries ago, but it is applicable in so many ways.
A new publication in the May issue of Nature Aging by researchers from Integrated Biosciences, a biotechnology company combining synthetic biology and machine learning to target aging, demonstrates the power of artificial intelligence (AI) to discover novel senolytic compounds, a class of small molecules under intense study for their ability to suppress age-related processes such as fibrosis, inflammation and cancer.
Cancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patients get the same benefit from these powerful therapies.
Researchers at Umeå University, Sweden, have found that among the many factors that shape the intestinal microbiota composition, diet has a much stronger impact than defensins, which are intestinal defence molecules produced by the body.
The atmosphere is a huge dissemination route for bacteria bearing antibiotic-resistance genes. Clouds can transport these genes, according to a team of researchers from Université Laval and Université Clermont Auvergne.
Researchers at NYU Grossman School of Medicine and Janssen Biotech, Inc. have shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus aureus – a bacterial species widely resistant to antibiotics and a major cause of death in hospitalized patients.
A multinational research group has uncovered how the bacterial toxin Ssp may penetrate and kill a wide variety of living cells, including human cells.
Alfalfa, also known in Latin as Medicago sativa, is an agricultural crop that is part of the legume family. It is known as a protein-rich food source for dairy cattle that is easily digested and can lead to increased milk production.
A new type of drug could provide a way to treat multidrug-resistant bacteria, according to a study published in Nature Communications.